PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-Aug-2023 ImmunityBio Names Enrique Diloné as Chief Technology Officer Businesswire
03-Aug-2023 Empower Aesthetics Announces Appointments to its Board of Directors Businesswire
03-Aug-2023 Sypris Wins Award for Venture Global CP2 LNG Export Terminal and Venture Global CP Express Natural Gas Pipeline Project Businesswire
03-Aug-2023 Legend Biotech to Host Investor Conference Call on Second-Quarter Results Businesswire
03-Aug-2023 Longboard Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
03-Aug-2023 RS Oncology presents new drug in early clinical development for Mesothelioma and lung cancer patients Businesswire
03-Aug-2023 Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine Businesswire
03-Aug-2023 Agilent Announces Thought Leader Award to Peter Neubauer Businesswire
03-Aug-2023 Amber Bio Raises $26 Million Seed Financing Co-Led by Playground Global and Andreessen Horowitz to Advance New RNA-Based Gene Editing Platform Businesswire
03-Aug-2023 AdaptHealth Corp. to Participate in the Canaccord Genuity 43rd Annual Growth Conference Businesswire
03-Aug-2023 Lineage Cell Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Update on August 10, 2023 Businesswire
03-Aug-2023 MindMed Announces Exclusive License Agreement With Catalent for Its Patented Zydis® Fast-Dissolve Technology for Use with MM-120 Businesswire
03-Aug-2023 Axcella Reports Second Quarter Financial Results and Provides Business Update Businesswire
03-Aug-2023 Areteia Therapeutics Announces Publication of Phase II Data of Oral Dexpramipexole in Eosinophilic Asthma Businesswire
03-Aug-2023 Global Dementia Clinical Trial Analysis Research 2023: Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries - ResearchAndMarkets.com Businesswire
03-Aug-2023 Myelofibrosis Market Size and Trend Report 2023-2031: Projected $2.89 Billion Market by 2031 - MF Pipeline is Robust, with Plenty of Room for New Market Entrants - ResearchAndMarkets.com Businesswire
03-Aug-2023 Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Clinical Trial of CEL383, an Anti-TREM1 Antibody for the Treatment of Inflammatory Bowel Disease Businesswire
03-Aug-2023 Coya Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023 Businesswire
03-Aug-2023 Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update Businesswire
03-Aug-2023 Click Therapeutics Announces Participation in Upcoming Technology and Biotechnology Investor Events Businesswire